(Q36168697)

12 August 2017

1 reference

title

Molecular prognostic factors in diffuse large B-cell lymphoma (English)

1 reference

12 August 2017

2

Izidore S Lossos

1 reference

12 August 2017

Daniel Morgensztern

1

1 reference

12 August 2017

1 July 2005

1 reference

Current Treatment Options in Oncology

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

4

1 reference

12 August 2017

269-277

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-005-0031-0

12 August 2017

0 references

cites work

Building an outcome predictor model for diffuse large B-cell lymphoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-005-0031-0

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

12 December 2020

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

12 December 2020

Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas

1 reference

12 December 2020

Molecular interactions on microarrays

1 reference

12 December 2020

Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data

1 reference

12 December 2020

Cell adhesion receptors in lymphoma dissemination

1 reference

12 December 2020

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

12 December 2020

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

1 reference

12 December 2020

A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'

1 reference

12 December 2020

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

1 reference

12 December 2020

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

12 December 2020

Occurrence and prognosis of extranodal lymphomas

1 reference

12 December 2020

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.

1 reference

12 December 2020

Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome

1 reference

12 December 2020

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

12 December 2020

Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development

1 reference

12 December 2020

The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma

1 reference

12 December 2020

CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.

1 reference

12 December 2020

Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1 reference

12 December 2020

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

1 reference

12 December 2020

Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.

1 reference

12 December 2020

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

1 reference

12 December 2020

The use and analysis of microarray data

1 reference

12 December 2020

Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma

1 reference

12 December 2020

Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study

1 reference

12 December 2020

Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD

1 reference

12 December 2020

LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients.

1 reference

12 December 2020

Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

1 reference

12 December 2020

Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study

1 reference

12 December 2020

Molecular interactions between stromal cells and B lymphocyte precursors

1 reference

12 December 2020

CD10 expression in diffuse large B-cell lymphomas does not influence survival

1 reference

12 December 2020

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

12 December 2020

Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas

1 reference

12 December 2020

Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance

1 reference

12 December 2020

Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma

1 reference

12 December 2020

Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma

1 reference

12 December 2020

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels

1 reference

12 December 2020

Human disease characterization: real-time quantitative PCR analysis of gene expression

1 reference

12 December 2020

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.

1 reference

12 December 2020

CD44--a molecule involved in leukocyte adherence and T-cell activation

1 reference

12 December 2020

Homing receptors and the control of lymphocyte migration

1 reference

12 December 2020

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs

1 reference

12 December 2020

Prognostic significance of bcl‐2, bax, and p53 expression in diffuse large B‐cell lymphoma

1 reference

12 December 2020

Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma

1 reference

12 December 2020

Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients.

1 reference

12 December 2020

Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation

1 reference

12 December 2020

The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas

1 reference

12 December 2020

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

12 December 2020

Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.

1 reference

12 December 2020

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

1 reference

12 December 2020

Report of the Committee on Hodgkin's Disease Staging Classification

1 reference

12 December 2020

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

12 December 2020

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

1 reference

12 December 2020

10.1007/S11864-005-0031-0

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15967080